Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-27

Clinical Trial Update: Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial [Phase 1, Phase 2]

View source ↗

Summary

A randomized controlled trial in preterm infants tested early enteral granulocyte colony-stimulating factor and erythropoietin and found increased feeding toler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)
  • Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Ain Shams University | Conditions: Feeding Intolerance, Necrotizing Enterocolitis | Phase 1, Phase 2 | Status: COMPLETED